Seres Therapeutics Q1 EPS $(2.08) Misses $(1.88) Estimate, Sales $358.000K
Seres Therapeutics (NASDAQ:MCRB) reported quarterly losses of $(2.08) per share which missed the analyst consensus estimate of $(1.88) by 10.64 percent. This is a 155.47 percent decrease over earnings of $3.75 per share
